Novel Approaches to Improve Speed of Development, Stability, Manufacturability, Quality and Fundamental Understanding
Alternate Language Options:
June 21 - 23, 2010 · San Francisco Airport Marriott · Burlingame, CA
Document Title
Sponsors
Updated: April 19, 2010
Silver Sponsor
DSM Biologics in partnership with Crucell N.V., offers the PER.C6® human cell line production platform for recombinant proteins and monoclonal antibodies. Standardized processes for the PER.C6® platform yield up to 8g/L in fed-batch mode and up to 27g/L utilizing the XD™ process technology. The combination of the PER.C6® platform and DSM's contract manufacturing services and process technology like the XD™ process provide companies with a turn-key biologic manufacturing solution reducing cost, risk and time to market.